Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea, Pain, Pain in extremity
Clinical narrative: hurt when injected and pain persisted/sore; Arm pain; muscle soreness; felt very nauseous/nausea; headache; loss of appetite; felt weak; tired; felt unwell; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 15:00 (Lot number: ER8732) at the age of 25 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "asthma" (unspecified if ongoing); "environmental allergies" (unspecified if ongoing). Concomitant medication(s) included: ZOLOFT; ZYRTEC ALLERGY; DAPSONE; EPIDUO-FORTE; ALBUTEROL HFA. Past drug history included: Chlorhexidine gluconate, reaction(s): "Known allergies to Chlorhexidine gluconate". Vaccination history included: Bnt162b2 (Dose number=1, Administration time=18:00 , Vaccine location=Left arm, Lot number=EN6199), administration date: 10Mar2021, when the patient was 25 years old, for COVID-19 Immunization, reaction(s): "very minor lightheaded feeling", "minor arm soreness for 24 hrs". The following information was reported: PAIN (non-serious) with onset 01Apr2021 02:30, outcome "recovered" (Apr2021), described as "hurt when injected and pain persisted/sore"; PAIN IN EXTREMITY (non-serious) with onset 01Apr2021 02:30, outcome "recovered" (Apr2021), described as "Arm pain"; MYALGIA (non-serious) with onset 01Apr2021 02:30, outcome "recovered" (Apr2021), described as "muscle soreness"; NAUSEA (non-serious) with onset 01Apr2021 02:30, outcome "recovered" (Apr2021), described as "felt very nauseous/nausea"; HEADACHE (non-serious) with onset 01Apr2021 02:30, outcome "recovered" (Apr2021), described as "headache"; DECREASED APPETITE (non-serious) with onset 01Apr2021 02:30, outcome "recovered" (Apr2021), described as "loss of appetite"; ASTHENIA (non-serious) with onset 01Apr2021 02:30, outcome "recovered" (Apr2021), described as "felt weak"; FATIGUE (non-serious) with onset 01Apr2021 02:30, outcome "recovered" (Apr2021), described as "tired"; MALAISE (non-serious) with onset 01Apr2021 02:30, outcome "recovered" (Apr2021), described as "felt unwell". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain, pain in extremity, myalgia, nausea, headache. Therapeutic measures were not taken as a result of decreased appetite, asthenia, fatigue, malaise.  Additional information: It was reported that, after 2nd injection patient had hurt when injected and pain persisted. Arm pain and muscle soreness persisted for at least 48 hours after injection -Woke up to accidental alarm on phone at 2:30am- felt very nauseous and had headache -In the morning- had bad headache and nausea; no fever detected via infrared forehead thermometer -Ate a little food and took 200mg 2x ibuprofen -After food, nausea subsided, ~8am but loss of appetite persisted all day -Headache lasted all day, but lessened with ibuprofen. Worsened when walking around house, better when just sitting -Felt better by end of the day, but still felt weak, tired, and sore. overall felt unwell. -Overall, felt much better when woke the next morning. Patient received vaccine at Public Health Clinic/Veterans Administration facility. Patient did not receive any other vaccines within 4 weeks prior and received other medications 2 weeks prior to the COVID vaccine. The patient was not tested positive for covid 19 prior to vaccination and had not been tested post vaccination.  No follow-up attempts are possible. No further information is expected.